| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |